June 19th, 2026 | 07:00 CEST
Winners and Losers of the Energy Transition: Cameco Strong, Nel ASA Disappoints, American Atomics Positions Itself
The global energy market is in flux, and stocks across the various sectors are either soaring or plummeting. While the world continues to watch with bated breath the historic peace agreement between the US and Iran—a deal expected to reopen the Strait of Hormuz and noticeably calm global markets—a similarly dramatic transformation is underway in the energy sector. Investors are currently experiencing a rollercoaster of emotions, because while established uranium giants like Cameco are benefiting from the renaissance of nuclear power, Nel ASA is fighting for its future following massive declines in orders. In the background, a smaller stock is poised to make big waves. American Atomics has strategically positioned itself to meet the growing demand for nuclear energy in the US. In a post-war world craving security and independence, Cameco, Nel ASA, and American Atomics are showing who might be among the winners in the reshaping of the energy supply—and who might be left behind.
time to read: 4 minutes | Author: Matthias Schomber
ISIN: AMERICAN ATOMICS INC | CA0240301089 | CSE: NUKE , NEL ASA NK-_20 | NO0010081235 , CAMECO CORP. | CA13321L1085
Table of contents:
Author
Matthias Schomber
Raised in Giessen, Hesse, Matthias Schomber discovered his passion for the financial markets as early as the 1990s—at a time when stock trading was still largely the domain of true, die-hard traders. After completing his banking apprenticeship, he worked for a private bank there and witnessed the rise and fall of the Neuer Markt firsthand on the trading floor of the Frankfurt Stock Exchange, drawing lessons from the experience that continue to shape his thinking as a trader, author, and trading system developer to this day.
Tag cloud
Shares cloud
Cameco: A Shining Winner
Cameco is undoubtedly one of the current winners in the energy sector. Global demand for uranium is surging as more and more countries turn back to nuclear energy to meet their energy needs. The Canadian company is benefiting enormously from this trend. Recently, the company further expanded its position by acquiring an additional 2.871% stake in the Cigar Lake project for approximately CAD 115.75 million. The seller was TEPCO Resources. As a result of this deal, Cameco now holds an impressive 57.418% stake in this significant uranium deposit.
This strength is also reflected on the stock market. The share recently regained and defended the psychologically important USD 100 mark and is currently trading at just under USD 105. While it still has some way to go before reaching its last high of just over USD 135, the trend remains positive. After all, in April 2025—just over a year ago—the share was still trading at just under USD 35. Since then, it has performed exceptionally well. With long-term supply contracts averaging 28 million pounds of uranium per year through 2030, the company has also secured excellent predictability. Most analysts are bullish and are setting price targets of up to USD 202. Cameco is thus delivering solid results and cementing its status as a core investment in the uranium sector. There could still be room for the stock to rise.
Nel ASA: In Free Fall
From the booming uranium market, we now turn our attention to the hydrogen sector, which is currently partly booming again but partly in crisis. Compared to Cameco, Nel ASA presents a completely different picture. The Norwegian company is in rough waters. In the first quarter of 2026, order intake plummeted by a staggering 73% to just NOK 85 million. EBITDA remained deep in the red at minus NOK 100 million. As if that were not enough, CEO Hakon Volldal is now also leaving the company. He will depart no later than the end of his six-month notice period.
The stock market reacted promptly, sending the stock on a downward spiral. The share lost more than 20% over the month and was last trading in the EUR 0.21-0.23 range. At least Nel ASA still has cash and cash equivalents totaling NOK 1.4 billion. There is also hope for a new alkaline pressure electrolysis platform, which is expected to drastically reduce production costs. However, without any tangible new major orders, the situation remains extremely tense for investors. It is better to wait and see from the sidelines!
American Atomics: The Challenger
While Nel ASA is in crisis and Cameco is already an established giant, it is worth taking a look at an up-and-coming player. American Atomics is positioning itself strategically in a niche market that has become increasingly important amid geopolitical tensions. The company is pursuing a clear "Rocks to Reactor" strategy. The goal is to rebuild the American supply chain for the nuclear fuel cycle.
A closer look at the company's latest presentation reveals a well-thought-out concept. American Atomics is relying on a hub-and-spoke model. At the center is the planned construction of a uranium mill in the US, to be carried out through a joint venture with CVMR. The flagship exploration project is located in the Big Indian District in Utah's Lisbon Valley. While approximately 78 million pounds of uranium have historically been mined on the western flank, American Atomics now intends to develop the eastern flank, which has been scarcely explored. Management anticipates mirror-image deposits. The Blue Streak project in Colorado is also set to become an important source of supply for the planned mill.
On June 1, there was encouraging news specifically regarding this Blue Streak project. The company published an initial mineral resource estimate. Historical data from the Pickett Corral Mine show grades of 0.29% uranium and 1.92% vanadium. Shortly thereafter, on June 3, a strategic coup followed. Dr. Tomas J. Philipson was appointed Chairman of the Advisory Board. As the former Director of the Council of Economic Advisers at the White House, he brings an enormous political network to the table. His experience aligns perfectly with American Atomics' plans to strengthen the independence of the US uranium supply. Finally, on June 5, the company announced the successful change of its OTCQB ticker symbol to NUKUF and its DTC eligibility (FAST). This makes trading easier for US investors and should lead to increased liquidity for the stock.
Is History Repeating Itself?
History often repeats itself on the stock market. Looking at the chart of American Atomics, the share is currently trading at roughly the same level from which its rapid rise to just under CAD 1 began in April 2025. For a clear technical buy signal, the stock must break above the CAD 0.35 mark. If this breakout succeeds, a rapid rise toward CAD 0.60 to 0.70 is entirely realistic. The latest fundamental developments and the company's strategic positioning in the US should, in any case, provide a solid foundation for such an upward move.
The energy market remains dynamic and challenging. Cameco is the near-perfect core investment for anyone looking to capitalize on security and market power in the booming uranium sector. The Canadian company is delivering strong results and making strategically sound acquisitions. Nel ASA, on the other hand, remains a risky restructuring scenario for the time being. The lack of new orders and the leadership transition require investors to be patient and have strong nerves. American Atomics, on the other hand, offers a refreshingly different perspective. The company is still in its early stages, but it is positioning itself strategically within the politically driven effort to build a domestic US uranium supply chain. Investors willing to accept a certain level of risk may find a highly compelling opportunity here with significant upside potential.
Conflict of interest
Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.
In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.
For this reason, there is a concrete conflict of interest.
The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.
Risk notice
Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.
The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.
The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.
